285 related articles for article (PubMed ID: 32559814)
1. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
Moss J; Jani Y; Edwards B; Tomlin S; Rashed AN
Br J Clin Pharmacol; 2021 Mar; 87(3):816-824. PubMed ID: 32559814
[TBL] [Abstract][Full Text] [Related]
2. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.
Sheikh A; Simons FE; Barbour V; Worth A
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008935. PubMed ID: 22895980
[TBL] [Abstract][Full Text] [Related]
3. Epinephrine auto-injector needle length: what is the ideal length?
Song TT; Lieberman P
Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):361-5. PubMed ID: 27271769
[TBL] [Abstract][Full Text] [Related]
4. What are the 'ideal' features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis?
Frew AJ
Allergy; 2011 Jan; 66(1):15-24. PubMed ID: 20716315
[TBL] [Abstract][Full Text] [Related]
5. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK.
Gallagher M; Worth A; Cunningham-Burley S; Sheikh A
Clin Exp Allergy; 2011 Jun; 41(6):869-77. PubMed ID: 21481022
[TBL] [Abstract][Full Text] [Related]
6. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.
Ridolo E; Montagni M; Bonzano L; Savi E; Peveri S; Costantino MT; Crivellaro M; Manzotti G; Lombardi C; Caminati M; Incorvaia C; Senna G
Intern Emerg Med; 2015 Dec; 10(8):937-41. PubMed ID: 25990486
[TBL] [Abstract][Full Text] [Related]
7. Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study.
Patel N; Isaacs E; Duca B; Nagaratnam N; Donovan J; Fontanella S; Turner PJ
Allergy; 2023 Jul; 78(7):1997-2006. PubMed ID: 36794963
[TBL] [Abstract][Full Text] [Related]
8. Epinephrine auto-injector pandemic.
Campbell RL; Manivannan V; Hartz MF; Sadosty AT
Pediatr Emerg Care; 2012 Sep; 28(9):938-42. PubMed ID: 22940899
[TBL] [Abstract][Full Text] [Related]
9. Detecting epinephrine auto-injector shortages in Finland 2016-2022: Log-data analysis of online information seeking.
Mukka M; Pesälä S; Mustonen P; Kaila M; Helve O
PLoS One; 2024; 19(4):e0299092. PubMed ID: 38603709
[TBL] [Abstract][Full Text] [Related]
10. Anaphylaxis treatment: current barriers to adrenaline auto-injector use.
Song TT; Worm M; Lieberman P
Allergy; 2014 Aug; 69(8):983-91. PubMed ID: 24835773
[TBL] [Abstract][Full Text] [Related]
11. Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department.
Mostmans Y; Grosber M; Blykers M; Mols P; Naeije N; Gutermuth J
Allergy; 2017 Mar; 72(3):492-497. PubMed ID: 27709624
[TBL] [Abstract][Full Text] [Related]
12. Anaphylaxis and onsite treatment in schools, kindergartens, and nurseries.
Korematsu S; Kaku M; Kitada S; Etoh M; Kai H; Joh M; Nakano K; Nakamura M; Sato K; Wakita Y; Matsumoto S; Yada K; Andou A; Ishiwa S; Fujimoto T
Pediatr Int; 2022 Jan; 64(1):e14973. PubMed ID: 34459057
[TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?
Fitzharris P; Empson M; Ameratunga R; Sinclair J; Crump V; Steele R; Broom B
N Z Med J; 2006 May; 119(1233):U1965. PubMed ID: 16680178
[TBL] [Abstract][Full Text] [Related]
14. Management and treatment of anaphylaxis in children: still too low the rate of prescription and administration of intramuscular epinephrine.
Calamelli E; Mattana F; Cipriani F; Ricci G
Int J Immunopathol Pharmacol; 2014; 27(4):597-605. PubMed ID: 25572739
[TBL] [Abstract][Full Text] [Related]
15. Adrenaline auto-injector injuries: Practical considerations in emergency management in a tertiary hand surgery unit.
McCaughran PW; Ellis K; Southall C; Zargaran D; Nikkhah D; Mosahebi A
Medicine (Baltimore); 2023 Mar; 102(10):e32977. PubMed ID: 36897675
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and cardiovascular effects of adrenaline administered by Anapen 500 μg auto-injector in healthy volunteers.
Duvauchelle T; Robert P; Donazzolo Y; Loyau S; Orlandini B; Lehert P; Lecomte JM; Schwartz JC
Br J Clin Pharmacol; 2023 Mar; 89(3):1012-1019. PubMed ID: 36136762
[TBL] [Abstract][Full Text] [Related]
17. Identifying the factors and root causes associated with the unintentional usage of an adrenaline auto-injector in Japanese children and their caregivers.
Sasaki K; Nakagawa T; Sugiura S; Ebisawa M; Ito K
Allergol Int; 2018 Oct; 67(4):475-480. PubMed ID: 29519764
[TBL] [Abstract][Full Text] [Related]
18. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective.
Simons E; Sicherer SH; Simons FE
Ann Allergy Asthma Immunol; 2012 May; 108(5):321-5. PubMed ID: 22541402
[TBL] [Abstract][Full Text] [Related]
19. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community.
Simons FE;
Ann Allergy Asthma Immunol; 2009 May; 102(5):403-9. PubMed ID: 19492662
[TBL] [Abstract][Full Text] [Related]
20. Administration of the adrenaline auto-injector at the nursery/kindergarten/school in Western Japan.
Korematsu S; Fujitaka M; Ogata M; Zaitsu M; Motomura C; Kuzume K; Toku Y; Ikeda M; Odajima H
Asia Pac Allergy; 2017 Jan; 7(1):37-41. PubMed ID: 28154804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
